skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:057044/0548   Pages: 3
Recorded: 07/26/2021
Attorney Dkt #:538310US-SD
Conveyance: CHANGE OF ADDRESS
Total properties: 17
1
Patent #:
Issue Dt:
04/12/2016
Application #:
13861619
Filing Dt:
04/12/2013
Publication #:
Pub Dt:
03/13/2014
Title:
A Monoclonal Antibody Specifically Recognizing an Epitope for Switching to Th17 Cell
2
Patent #:
Issue Dt:
02/09/2016
Application #:
13861644
Filing Dt:
04/12/2013
Publication #:
Pub Dt:
03/06/2014
Title:
AN ANTIBODY SPECIFICALLY RECOGNIZING AN EPITOPE FOR SWITCHING TO TH1 CELL
3
Patent #:
Issue Dt:
02/09/2016
Application #:
13861675
Filing Dt:
04/12/2013
Publication #:
Pub Dt:
03/13/2014
Title:
AN ANTIBODY SPECIFICALLY RECOGNIZING AN EPITOPE FOR SWITCHING TO TH2 CELL AND A METHOD FOR CONVERTING T CELL TO TYPE 2 HELPER T CELL USING THE SAME
4
Patent #:
Issue Dt:
01/09/2018
Application #:
14639679
Filing Dt:
03/05/2015
Publication #:
Pub Dt:
10/26/2017
Title:
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof
5
Patent #:
Issue Dt:
11/12/2019
Application #:
15307820
Filing Dt:
10/29/2016
Publication #:
Pub Dt:
06/22/2017
Title:
HAR-NDS-DERIVED STEM CELLS, METHOD FOR SEPARATING SAME, AND USE THEREOF
6
Patent #:
Issue Dt:
10/13/2020
Application #:
15691179
Filing Dt:
08/30/2017
Publication #:
Pub Dt:
03/01/2018
Title:
METHODS FOR ISOLATING AND PROLIFERATING AUTOLOGOUS CANCER ANTIGEN-SPECIFIC CD8+ T CELLS
7
Patent #:
Issue Dt:
12/01/2020
Application #:
15815396
Filing Dt:
11/16/2017
Publication #:
Pub Dt:
06/21/2018
Title:
NOVEL EPITOPE FOR SWITCHING TO TH17 CELL AND USE THEREOF
8
Patent #:
Issue Dt:
03/19/2019
Application #:
15829048
Filing Dt:
12/01/2017
Publication #:
Pub Dt:
06/21/2018
Title:
MONOCLONAL ANTIBODY WHICH SPECIFICALLY RECOGNIZES B CELL LYMPHOMA AND USE THEREOF
9
Patent #:
Issue Dt:
01/08/2019
Application #:
15863526
Filing Dt:
01/05/2018
Publication #:
Pub Dt:
09/13/2018
Title:
ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF
10
Patent #:
Issue Dt:
07/06/2021
Application #:
15866061
Filing Dt:
01/09/2018
Publication #:
Pub Dt:
12/27/2018
Title:
Novel Epitope for Switching to TH2 Cell and Use Thereof
11
Patent #:
Issue Dt:
02/25/2020
Application #:
15936209
Filing Dt:
03/26/2018
Publication #:
Pub Dt:
08/02/2018
Title:
METHODS FOR ISOLATING AND PROLIFERATING AUTOLOGOUS CANCER ANTIGEN-SPECIFIC CD8+ T CELLS
12
Patent #:
Issue Dt:
02/16/2021
Application #:
16191381
Filing Dt:
11/14/2018
Publication #:
Pub Dt:
03/07/2019
Title:
ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF
13
Patent #:
Issue Dt:
02/16/2021
Application #:
16239398
Filing Dt:
01/03/2019
Publication #:
Pub Dt:
10/31/2019
Title:
IFN-Gamma-Inducible Regulatory T Cell Convertible Anti-Cancer (IRTCA) Antibody and Uses Thereof
14
Patent #:
Issue Dt:
04/21/2020
Application #:
16255690
Filing Dt:
01/23/2019
Publication #:
Pub Dt:
08/01/2019
Title:
IFN-Gamma-Inducible Regulatory T Cell Convertible Anti-Cancer (IRTCA) Antibody and Uses Thereof
15
Patent #:
Issue Dt:
05/25/2021
Application #:
16715462
Filing Dt:
12/16/2019
Publication #:
Pub Dt:
07/30/2020
Title:
CHIMERIC ANTIGEN RECEPTOR THAT BINDS HLA-DR AND CAR-T CELL
16
Patent #:
Issue Dt:
09/15/2020
Application #:
16790299
Filing Dt:
02/13/2020
Publication #:
Pub Dt:
06/04/2020
Title:
ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF
17
Patent #:
Issue Dt:
02/23/2021
Application #:
16838887
Filing Dt:
04/02/2020
Publication #:
Pub Dt:
09/17/2020
Title:
ANTI-HUMAN VSIG4 ANTIBODIES AND USES THEREOF
Assignor
1
Exec Dt:
07/26/2021
Assignee
1
SUITE 408 ACE HANSOL TOWER
GASAN DIGITAL 1RO 58, GEUMCHEON-GU
SEOUL, KOREA, REPUBLIC OF 08591
Correspondence name and address
OBLON, ET AL.
1940 DUKE STREET
ALEXANDRIA, VA 22314

Search Results as of: 05/22/2024 07:16 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT